Weight-loss drug Wegovy to begin sales in Korea after 16-month wait

An injection pen of Novo Nordisk's weight-loss drug Wegovy in Oslo, Norway, September 1, 2023. [REUTERS/YONHAP]

 
Weight-loss drug Wegovy will go on sale in the Korean market next month, about a year and a half after receiving regulatory approval in the country.
 

Related Article

• Korean ETFs chase heavy gains on weight-loss drugs

• Korean pharmas jump on weight loss drug boom

• [INTERVIEW] Pharma firms playing pivotal role in obesity epidemic battle

 
According to Novo Nordisk Korea, Wegovy's pre-filled syringe will be released in mid-October. The obesity drug was approved by the Ministry of Food and Drug Safety in April last year. 
 
Wegovy, a once-weekly injectable prescription drug, mimics the action of a gut hormone called GLP-1, helping to regulate appetite and food intake.

BY SHIN HA-NEE [shin.hanee@joongang.co.kr]